Issue: November 2012
November 01, 2012
1 min read
Save

Aldo-DHF

Issue: November 2012
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Trial tested effects of 1 year of spironolactone treatment on cardiac function and structure, exercise capacity and quality of life in patients with symptomatic hypertensive diastolic HF.

Aldo-DHF